Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of ICAC-01 is to determine whether an asthma treatment strategy that measures
exhaled nitric oxide (eNO) to indicate disease progression is more effective in treating
asthma symptoms when combined with existing asthma treatment guidelines than treatment using
the guidelines alone.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)